(PDF) Dopamine Receptor Antagonism by the Novel Antianxiety

Dopamine Receptor Antagonism by the Novel Antianxiety Drug, Buspirone

Journal of Neuroscience - United States

doi 10.1523/jneurosci.03-04-00733.1983

Full Text

Abstract

Available in full text

Categories

Date

April 1, 1983

Authors

Publisher

Society for Neuroscience

Related search

Dopamine D2 Receptor Antagonism Suppresses Tau Aggregation and Neurotoxicity

Biological Psychiatry

Biological Psychiatry

English

Differential Modulation of Reinforcement Learning by D2 Dopamine and NMDA Glutamate Receptor Antagonism

Journal of Neuroscience

English

New Dopamine Receptor Stimulant Drug

Cellular and Molecular Life Sciences

Molecular Neuroscience

Molecular Medicine

Molecular Biology

English

Effects of Dopamine D2/D3 Receptor Antagonism on Human Planning and Spatial Working Memory

Translational Psychiatry

Molecular Neuroscience

Biological Psychiatry

English

Analysis of the Actions of the Novel Dopamine Receptor-Directed Compounds (S)-Osu6162 and ACR16 at the D2 Dopamine Receptor

British Journal of Pharmacology

English

Dopamine Receptor D4 Promoter Hypermethylation Increases the Risk of Drug Addiction

Experimental and Therapeutic Medicine

Cancer Research

English

Antagonism of Dopamine D2 Receptor/ -Arrestin 2 Interaction Is a Common Property of Clinically Effective Antipsychotics

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Typical and Atypical Antipsychotics Do Not Differ Markedly in Their Reversibility of Antagonism of the Dopamine D2 Receptor

International Journal of Neuropsychopharmacology

English

Effects of Dopamine Receptor Antagonism and Amphetamine Sensitization on Sign- And Goal-Tracking After Extended Training

English